Dan Bi

Dan Bi

Auto-generated profile, based on publicly available information

Dan Bi

Beijing Yiling Pharmaceutical Co., Ltd., Beijing 102600, P. R. China; Hebei Academy of Integrated Tr

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in Records of Natural Products
Verified
Journal Article
Closed access
CZChuangfeng Zhang
Chuangfeng Zhang
SYSun Yunbo
Sun Yunbo
TWTongxing Wang
Tongxing Wang
SSShuo Shen
Shuo Shen
DBDan Bi
Dan Bi
ZJZhenhua Jia
Zhenhua Jia
Three new chromone glycosides, named 2-methyl-5-hydroxyl-4-chromone-7-O-β-D-glucuronide (1), 2-ethyl-5-hydroxyl-4-chromone-7-O-β-D-glucuronide (2) and 1-acetyl-3-C-β-D-glucopyranosyl-5-methyl-phloroglucinyl-6-O-β-D-glucopyranoside (6), together with eight known compounds were isolated from the water extract of Dryopteris crassirhizoma Nakai,and the water extract preparation process is consistent with Lianhua Qingwen capsule. All the chemical structures of new compounds were characterized by 1D and 2D NMR spectra as well as high resolution mass and IR spectra. The chemical structures of known compounds were characterized by NMR spectra along with comparison of their spectroscopic data with those reported in the literature. The binding ability of these compounds to 3CL hydrolase of SARS-COV-2 was evaluated by molecular docking. The results showed that the chromone glycosides with glucuronic acid fragment had good docking effect with 3CL hydrolase and this indicated the chromone glucuronides could be further studied as potential antiviral compounds.